Since targeting Akt-related signal is a promising strategy for CSC-directed therapy in lung cancer [25], the previous findings on TDB have prompted further interest in the potential of this natural bibenzyl to target lung CSCs, a facet which has not yet been explored. This evidence concerns the gene AKT1 and lung carcinoma.